These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

667 related items for PubMed ID: 24314948

  • 1. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z, Uyar ME, Tutal E, Erdogan E, Colak T, Sezer S, Haberal M.
    Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
    [Abstract] [Full Text] [Related]

  • 2. Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.
    Kekik C, Besisik SK, Seyhun Y, Oguz FS, Sargin D, Carin MN.
    Transplant Proc; 2009 Nov; 41(9):3859-62. PubMed ID: 19917401
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients.
    Gabardi S, Asipenko N, Fleming J, Lor K, McDevitt-Potter L, Mohammed A, Rogers C, Tichy EM, Weng R, Lee RA.
    Transplantation; 2015 Jul; 99(7):1499-505. PubMed ID: 25643140
    [Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [Abstract] [Full Text] [Related]

  • 5. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
    Michelo CM, van der Meer A, Tijssen HJ, Zomer R, Stelma F, Hilbrands LB, Joosten I.
    Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
    [Abstract] [Full Text] [Related]

  • 6. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K, Sugawara Y, Mizuta K, Fujita H, Kadowaki T, Kokudo N.
    Clin Transpl; 2011 Jul; ():223-35. PubMed ID: 22755416
    [Abstract] [Full Text] [Related]

  • 7. The effect of donor-recipient cytomegalovirus serology on adult liver transplantation: a single center experience.
    Tryphonopoulos P, Weppler D, Morris MI, Russo C, Nishida S, Levi DM, Moon J, Tekin A, Selvaggi G, Island E, Arosemena L, Ruiz P, Tzakis AG.
    Transplantation; 2011 Nov 15; 92(9):1051-7. PubMed ID: 21876474
    [Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M, Gupta S, Goyal N, Vasudevan KR, Makki K, Dawar R, Sardana R, Lal N, Kumar A.
    Liver Transpl; 2012 Dec 15; 18(12):1448-55. PubMed ID: 22903934
    [Abstract] [Full Text] [Related]

  • 9. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M, Rajczy K, Telkes G, Hídvégi M, Péter A, Remport A, Korbonits M, Fazakas J, Toronyi E, Sárváry E, Kóbori L, Járay J.
    Nephrol Dial Transplant; 2008 Aug 15; 23(8):2673-8. PubMed ID: 18332066
    [Abstract] [Full Text] [Related]

  • 10. CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.
    Mikulska M, Raiola AM, Bruzzi P, Varaldo R, Annunziata S, Lamparelli T, Frassoni F, Tedone E, Galano B, Bacigalupo A, Viscoli C.
    Biol Blood Marrow Transplant; 2012 Jan 15; 18(1):92-9. PubMed ID: 21689774
    [Abstract] [Full Text] [Related]

  • 11. [Influence of HLA compatibility on cytomegalovirus infection in kidney transplantation].
    Pouteil-Noble C, Bétuel H, Raffaele P, Megri K, Louvier C, Lefrançois N, Bosshard S, Dubernard JM, Aymard M, Touraine JL.
    Presse Med; 1991 Nov 27; 20(40):2022-4. PubMed ID: 1662376
    [Abstract] [Full Text] [Related]

  • 12. The use of sirolimus in patients with recurrent cytomegalovirus infection after kidney transplantation: A retrospective case series analysis.
    Shendi AM, Hung RKY, Caplin B, Griffiths P, Harber M.
    Saudi J Kidney Dis Transpl; 2019 Nov 27; 30(3):606-614. PubMed ID: 31249224
    [Abstract] [Full Text] [Related]

  • 13. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec 27; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM, Marquez MA, Bazerbachi F, Schiff JR, Cattral MS, McGilvray ID, Norgate A, Selzner M, Rotstein C, Husain S.
    Clin Transplant; 2013 Dec 27; 27(4):503-9. PubMed ID: 23731387
    [Abstract] [Full Text] [Related]

  • 15. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.
    Vu D, Shah T, Ansari J, Sakharkar P, Yasir Q, Naraghi R, Hutchinson I, Min D.
    Transpl Infect Dis; 2014 Oct 27; 16(5):724-32. PubMed ID: 25208755
    [Abstract] [Full Text] [Related]

  • 16. Preemptive therapy versus valgancyclovir prophylaxis in cytomegalovirus-positive kidney transplant recipients receiving antithymocyte globulin induction.
    Couzi L, Helou S, Bachelet T, Martin S, Moreau K, Morel D, Lafon ME, Garrigue I, Merville P.
    Transplant Proc; 2012 Nov 27; 44(9):2809-13. PubMed ID: 23146529
    [Abstract] [Full Text] [Related]

  • 17. HLA compatibility index: does it have a role in patients after heart transplantation?
    Bedanova H, Orban M, Ondrasek J, Stepanova R, Nemec P.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar 27; 157(1):5-11. PubMed ID: 23446213
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology of cytomegalovirus infection after pancreas transplantation.
    Parsaik AK, Bhalla T, Dong M, Rostambeigi N, Dierkhising RA, Dean P, Abraham R, Prieto M, Kremers WK, Razonable RR, Kudva YC.
    Transplantation; 2011 Nov 15; 92(9):1044-50. PubMed ID: 21904269
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N, Holman MJ, Yang HC.
    Clin Transplant; 1997 Dec 15; 11(6):633-9. PubMed ID: 9408699
    [Abstract] [Full Text] [Related]

  • 20. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V.
    Transplantation; 2009 Feb 15; 87(3):436-44. PubMed ID: 19202451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.